<DOC>
	<DOCNO>NCT00532233</DOCNO>
	<brief_summary>The purpose study investigate QAX576 affect level interleukin 13 ( IL-13 ) patient idiopathic pulmonary fibrosis ( IPF ) .</brief_summary>
	<brief_title>SD , IL-13 Production Rate IPF</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<criteria>Men woman age 40 80 year confirm diagnosis idiopathic pulmonary fibrosis Both men woman must nonchildbearing potential . Additional information regard requirement available screening . Capability meet certain lung function test screen Nonsmokers No participation another clinical study within 4 week study start . Certain medical condition may exclude candidate participation . Blood loss donation 400 mL within 2 month study start Significant illness ( respiratory ) within 2 week study start Past medical personal close family history clinically significant ECG abnormality Connective tissue disorder Active infection history systemic parasitic infection Known hypersensitivity drug . History immunocompromise , include positive HIV test result . History drug alcohol abuse within 12 month study start Any condition may compromise patient safety</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Idiopathic Pulmonary Fibrosis</keyword>
</DOC>